Founded to revolutionize biotechnology, Carterra specializes in developing and commercializing advanced micro-array deposition technologies. The company’s core mission is to enhance the efficiency and accuracy of laboratory research through innovative multiplexing solutions. Carterra's flagship products include the Continuous Flow Microspotter (CFM), which features an array printing instrument and a microfluidic print head, enabling simultaneous deposition of multiple samples. Their market focus is on providing high-throughput screening tools for antibody discovery and small molecule drug development.

Carterra has garnered attention from notable figures in the biotech industry and has secured investment from prominent venture capital firms. The company has achieved significant milestones, including widespread adoption of its CFM technology in leading research institutions and pharmaceutical companies. Carterra's impact is evident in its contribution to accelerating drug discovery processes, thereby fostering advancements in medical research and therapeutic development.